Janice Drew

20 papers receiving 671 citations

Janice Drew's Hit Papers

Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis 2020 · 248 citations
2480+2+4Years since publication50100150200

Peers

Janice Drew
Comparison fields: 5 of 70
  • Dermatology 401
  • Immunology and Allergy 188
  • Immunology 273
  • Physiology 263
  • Rheumatology 151
Replace D. Toth with:
D. Toth Canada
Wendell C. Valdecantos United States
Tianshuang Wu United States
Jorge R. Georgakopoulos Canada
H.M. Ockenfels Germany
M. Ruer‐Mulard France
Nicole Dumont United States
Alexandra Gruber‐Wackernagel Austria
Mark BY Tang Singapore
Eleonora Cinelli Italy
Janice Drew relative to D. Toth Canada D. Toth's profile →
Citations per field
00.5×1.5×
D. Toth · 1×
Citations per year

Countries citing papers authored by Janice Drew

Since Specialization
Citations

This map shows the geographic impact of Janice Drew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janice Drew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janice Drew more than expected).

Fields of papers citing papers by Janice Drew

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janice Drew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janice Drew. The network helps show where Janice Drew may publish in the future.

Co-authors

The 25 scholars most cited alongside Janice Drew, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Janice Drew Line = papers co-authored together Janice Drew links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis
Hit paper breakdown →
2020248
2 2018121
3 2018101
4 201846
5 201830
6 201825
7 201921
8 201620
9 201816
10 201912
11 198712
12 202011
13 20217
14 20194
15 20174
16 20172
17 20171
18 20171
19 20181
20 20171

About Janice Drew

Janice Drew is a scholar working on Physiology, Immunology, Dermatology, Pathology and Forensic Medicine and Pediatrics, Perinatology and Child Health, having authored 21 papers that have together received 684 indexed citations. Recurring topics across this work include Sympathectomy and Hyperhidrosis Treatments (11 papers), Psoriasis: Treatment and Pathogenesis (6 papers), Dermatology and Skin Diseases (5 papers), Pharmaceutical studies and practices (4 papers), Nasolacrimal Duct Obstruction Treatments (3 papers), Natural Compound Pharmacology Studies (3 papers), Autoimmune Bullous Skin Diseases (3 papers) and Urticaria and Related Conditions (2 papers). The work is most often cited by research in Dermatology (401 citations), Immunology and Allergy (188 citations), Immunology (273 citations), Physiology (263 citations) and Rheumatology (151 citations). Janice Drew has collaborated with scholars based in United States, Germany and Belgium. Frequent co-authors include Andrew Blauvelt, Ramanan Gopalan, Lawrence F. Eichenfield, Amy S. Paller, April W. Armstrong, Emma Guttman‐Yassky, Eric L. Simpson, Daniel Burge, Luke Peterson and David M. Pariser. Their work appears in journals such as Journal of the American Academy of Dermatology, Pediatric Dermatology, American Journal of Clinical Dermatology, Journal of Surgical Research and JAMA Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact